Scrip Asia 100 - No rest for Asia's drug regulators
This article was originally published in Scrip
Executive Summary
Companies wanting to sell their products in our 10 selected national markets have to work with the following regulatory authorities and health ministries. Here we profile these agencies and highlight recent work of relevance to global and local pharma.
You may also be interested in...
Pharma Guidelines, ending 1 July 2011
Recently updated and newly issued documents
EuropaBio appoints new chairman
EuropaBio, the European biotech industry association, has appointed Stephan Tanda as its new association chair. Mr Tanda, a member of the managing board of life sciences and materials sciences firm DSM, succeeds GlaxoSmithKline's Andrea Rappagliosi, who will remain a member of the EuropaBio board.
Medtech Guidelines, ending 24 June 2011
Recently updated and newly issued documents